Cox Capital Management’s AstraZeneca AZN Stock Holding History

Cox Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.09M	Sell	21,552 -34	-0.2%	-$6.39K	2.27%	15
2026 Q1	$4.26M	Sell	21,586 -7,759	-26%	-$1.5M	2.83%	12
2025 Q4	$5.55M	Buy	29,345 +429	+1%	+$75.2K	3.45%	8
2025 Q3	$4.44M	Buy	28,916 +284	+1%	+$43K	2.9%	14
2025 Q2	$4M	Sell	28,632 -752	-3%	-$105K	2.73%	12
2025 Q1	$4.32M	Sell	29,384 -919	-3%	-$133K	3.15%	11
2024 Q4	$3.97M	Buy	30,303 +11,568	+62%	+$1.62M	2.55%	13
2024 Q3	$2.92M	Sell	18,735 -360	-2%	-$58.1K	1.75%	26
2024 Q2	$2.98M	Sell	19,095 -706	-4%	-$106K	1.8%	24
2024 Q1	$2.68M	Buy	+19,801	New	+$2.62M	1.65%	27

Other funds holding AZN

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BTCPP

Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

Cox Capital Management's AZN Position: Q2 2026 in Review

Cox Capital Management reduced its AstraZeneca (AZN) stake by 0.16% in Q2 2026, selling an estimated $6.39K and leaving 21,552 shares worth $4.09M. The position accounts for 2.27% of the portfolio, ranked #15.

Cox Capital Management first reported a position in AZN in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.55M in Q4 2025. 618 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Cox Capital Management held 21,552 shares of AstraZeneca worth $4.09M as of Q2 2026.
Cox Capital Management sold 34 AstraZeneca shares in Q2 2026, an estimated $6.39K.
AstraZeneca made up 2.27% of Cox Capital Management's portfolio in Q2 2026, its #15 holding.
Cox Capital Management first reported a position in AstraZeneca in Q1 2024 and has held it in 10 quarters since.
Cox Capital Management's AstraZeneca position peaked at $5.55M in Q4 2025.
618 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Cox Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.